Approval of Revised Consolidated Financial Results

The Board approved the Revised Audited Consolidated Financial Results for the quarter and financial year ended March 31, 2026, pursuant to Regulation 33 of the SEBI Listing Regulations.

The revision was carried out solely for incorporating the Consolidated Statement of Cash Flows together with consequential disclosures and references thereto. Specifically, there is no change whatsoever in the Consolidated Financial Results approved by the Board of Directors on May 28, 2026, except for the inclusion of the Consolidated Statement of Cash Flows.

Since there was no revision, modification or change in the Audited Standalone Financial Results approved by the Board on May 28, 2026, only the Revised Consolidated Financial Results are being submitted to the exchange.

The company enclosed the following documents:

  • Revised Audited Consolidated Financial Results including Consolidated Statement of Cash Flows for quarter and year ended March 31, 2026 with Independent Auditors' Report by M/s. N V C & Associates LLP, Chartered Accountants
  • Declaration pursuant to Regulation 33(3)(d) confirming unmodified audit opinions

Financial Results Details

The Revised Consolidated Financial Results show (all figures in ₹ lakhs):

Income Statement for Year Ended March 31, 2026:

  • Revenue from Operations: ₹1,334.75
  • Other Income: ₹5.31
  • Total Income: ₹1,340.06
  • Total Expenses: ₹1,565.68
  • Loss before Tax: (₹225.62)
  • Tax Credit: (₹4.21)
  • Net Loss for the year: (₹221.41)
  • Total Comprehensive Income: (₹207.61)
  • Basic and Diluted EPS: (₹3.69) per share
  • Paid-up Equity Share Capital: ₹600.00 (Face value ₹10 per share)
  • Other Equity: ₹77.62

Quarterly Performance (Q4 FY26 vs Q3 FY25):

  • Q4 Revenue from Operations: ₹196.65 vs ₹146.81
  • Q4 Total Income: ₹198.43 vs ₹148.11
  • Q4 Total Expenses: ₹291.58 vs ₹188.50
  • Q4 Loss before Tax: (₹93.15) vs (₹40.39)
  • Q4 Net Loss: (₹92.66) vs (₹37.50)
  • Q4 Basic and Diluted EPS: (₹1.54) vs (₹0.63)

Consolidated Cash Flow Statement for Year Ended March 31, 2026:

  • Loss before tax: (₹225.62)
  • Operating Profit before working capital changes: (₹181.88)
  • Cash flow from operations after working capital changes: ₹63.83
  • Net cash used in investing activities: (₹39.07)
  • Net cash flow from financing activities: Nil

BSE Non-Compliance Communication

The Board considered a communication received from BSE Limited dated June 30, 2026 regarding levy of fine under SEBI Master Circular for non-submission of Consolidated Statement of Cash Flows along with Consolidated Financial Results for quarter and year ended March 31, 2026.

The company had originally submitted Audited Standalone and Consolidated Financial Results on May 28, 2026. Subsequently, pursuant to observations from the Exchange and after obtaining professional advice regarding applicability of Indian Accounting Standard (Ind AS) 7, the company prepared the Consolidated Statement of Cash Flows using the indirect method by reconciling movement between Opening Standalone Financial Statements and Closing Consolidated Financial Statements.

The Board noted that the revision is limited solely to inclusion of the Consolidated Statement of Cash Flows and consequential disclosures/references, with no change in financial performance, financial position or any other financial information contained in the originally approved Consolidated Financial Results.

The Board was of the view that approval and submission of Revised Consolidated Financial Results adequately address the observations raised by the Exchange, while the Audited Standalone Financial Results approved on May 28, 2026 remain unchanged and valid.

Additional Context from Notes

The Revised Consolidated Financial Results relate to Daikaffil Chemicals India Limited and its subsidiary Mikusu Global Industries Limited (together referred to as "The Group").

The Group is engaged in manufacturing of OBA and Other Chemicals, falling within a single business segment with no separate reportable segments as per AS 108.

The company incorporated subsidiary Mikusu Global Industries Limited on August 22, 2025. During the year, the subsidiary started its activities and consolidated financial statements have been prepared for the first time for year ended March 31, 2026.

Due to first-time consolidation, comparative figures for quarter ended March 31, 2025, and year ended March 31, 2025 are not presented. Similarly, comparative balance sheet figures for March 31, 2025 are not presented.

The company has considered provisions of new labour code while computing employee benefits liability, with impact not being material.

Declaration

The company submitted a declaration confirming that statutory auditors have issued audit reports with unmodified opinion on Revised Consolidated Financial Results for quarter and financial year ended March 31, 2026.

Publication and Availability

The extract of the results will be published in newspapers in accordance with Listing Regulations. The financial results are also available on the company's website (www.daikaffil.com) and BSE website (www.bseindia.com).